✦ LIBER ✦

Safety and Feasibility of Achieving Lower Systolic Blood Pressure Goals in Persons With Type 2 Diabetes: The SANDS Trial

✍ Scribed by Matthew R. Weir; Fawn Yeh; Angela Silverman; Richard B. Devereux; James M. Galloway; Jeffrey A. Henderson; William J. Howard; Marie Russell; Charlton Wilson; Robert Ratner; John Sorkin; Jason G. Umans; Jerome L. Fleg; Mario Stylianou; Elisa Lee; Barbara V. Howard

Book ID: 114898857
Publisher: Le Jacq Communications, Inc.
Year: 2009
Tongue: English
Weight: 402 KB
Volume: 11
Category: Article
ISSN: 1524-6175
DOI: 10.1111/j.1751-7176.2009.00121.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement of glycaemic control by nate

Improvement of glycaemic control by nateglinide decreases systolic blood pressure in drug-naive patients with type 2 diabetes

✍ J.-M. González-Clemente; on behalf of the Spanish Nateglinide Study Group 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

The Health Impact of Getting to Glucose,

The Health Impact of Getting to Glucose, Systolic Blood Pressure (SBP), and Serum Cholesterol Goals in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) in Canada

✍ Teschemaker, Anna R.; Johansen, Pierre; Brazier, Nicole C.; Neslusan, Cheryl; Wi 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 48 KB

The effect of achieving a systolic blood

The effect of achieving a systolic blood pressure of 140 mmHg. A prospective study of ambulatory measurements in type 2 diabetic patients with nephropathy

✍ Ole Torffvit 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Proteinuria modifies the effect of systo

Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes

✍ T. Vepsäläinen; M. Laakso; I. Kantola; S. Lehto; A. Juutilainen; T. Rönnemaa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Time-to-effect relationships between sys

Time-to-effect relationships between systolic blood pressure and the risks of nephropathy and retinopathy in patients with type 2 diabetes

✍ Takao, Toshiko; Matsuyama, Yutaka; Suka, Machi; Yanagisawa, Hiroyuki; Kikuchi, M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Lowering Blood Pressure With β-Blockers

Lowering Blood Pressure With β-Blockers in Combination With Other Renin-Angiotensin System Blockers in Patients With Hypertension and Type 2 Diabetes: Results From the GEMINI Trial

✍ Jackson T. Wright Jr; George L. Bakris; David S. H. Bell; Vivian Fonseca; Richar 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 259 KB